<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Microsporidiosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Microsporidiosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Microsporidiosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karin Leder, MBBS, FRACP, PhD, MPH, DTMH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter F Weller, MD, MACP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Edward T Ryan, MD, DTMH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Milana Bogorodskaya, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 15, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microsporidia are intracellular spore-forming organisms that are ubiquitous in the environment and can infect a wide range of vertebrate and invertebrate hosts, including insects, birds, fish, and mammals. The clinical manifestations of microsporidiosis are diverse and include intestinal, pulmonary, ocular, muscular, and renal disease. Microsporidiosis has been identified in immunosuppressed hosts (eg, transplant recipients, patients with HIV), travelers, children, and older adults [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 220 genera and more than 1700 species of microsporidia have been described [
         <a href="#rid2">
          2
         </a>
         ]; they are classified based on spore size, nucleus arrangement, mode of replication within the host cell, host-parasite relationship, and rRNA analysis. Microsporidia were previously considered protozoa; they have been reclassified as fungi [
         <a href="#rid3">
          3
         </a>
         ]. Seventeen different species have been reported to infect humans, many of which were discovered as opportunistic infections in association with the AIDS epidemic  (
         <a class="graphic graphic_table graphicRef70473" href="/z/d/graphic/70473.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The spores vary in size; those that infect humans are typically oval and 1 to 4 microns in diameter  (
         <a class="graphic graphic_figure graphicRef78496" href="/z/d/graphic/78496.html" rel="external">
          figure 1
         </a>
         ). The spores are highly resistant to degradation and can survive in the environment for up to four months. Their structure is distinguished by the presence of a polar filament, which facilitates injection of the spore contents into the host cell.
        </p>
        <p>
         The most common species causing infection in humans is
         <em>
          Enterocytozoon bieneusi
         </em>
         , followed by the
         <em>
          Encephalitozoon
         </em>
         species, particularly
         <em>
          Encephalitozoon intestinalis
         </em>
         . Genome sequencing has shown high genetic diversity for
         <em>
          E. bieneusi
         </em>
         , with approximately 500 genotypes and 11 phylogenetic groups identified in humans, pets, livestock, birds, and environmental samples [
         <a href="#rid4">
          4
         </a>
         ]. Group 1 is the largest, containing over 300 genotypes, and Groups 1 and 2 have been divided into 9 and 3 subgroups, respectively. Many of the genotypes from Groups 1 and 2 have high potential for cross-species transmission and have been found in a broad range of hosts including humans [
         <a href="#rid4">
          4
         </a>
         ]. However, some genotypes for example, genotype B, have thus far been found only in humans. Groups 3 to 11 contain fewer genotypes, are more host specific, and have limited public health importance [
         <a href="#rid3">
          3,5
         </a>
         ]. Among
         <em>
          E. intestinalis
         </em>
         isolates, there have been no molecular differences observed among those originating from infected humans and infected animals, which may imply there is no transmission barrier between different
         <sup>
         </sup>
         host species. Other
         <em>
          Encephalitozoon
         </em>
         species causing human infection are
         <em>
          Encephalitozoon cuniculi
         </em>
         and
         <em>
          Encephalitozoon hellem
         </em>
         . Antigenic diversity has also been demonstrated among these isolates [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         <em>
          E. bieneusi
         </em>
         and
         <em>
          Encephalitozoon
         </em>
         species usually infect the gastrointestinal and biliary tracts, although there have been a few case reports of isolation of
         <em>
          E. bieneusi
         </em>
         from the respiratory tract [
         <a href="#rid8">
          8
         </a>
         ].
         <em>
          Enterocytozoon
         </em>
         infections normally cause localized infection; in contrast,
         <em>
          Encephalitozoon
         </em>
         species have the ability to disseminate widely via macrophages, thus causing systemic infection involving the intestinal and hepatobiliary tracts, respiratory tract, sinuses, kidney, eye, and brain.
        </p>
        <p>
         Several other species are capable of causing disseminated disease, including
         <em>
          Trachipleistophora
         </em>
         species (
         <em>
          Trachipleistophora hominis
         </em>
         and
         <em>
          Trachipleistophora anthropopthera
         </em>
         ),
         <em>
          Pleistophora
         </em>
         species (
         <em>
          Pleistophora ronneafiei
         </em>
         and others), and
         <em>
          Anncaliia
         </em>
         species, also known as
         <em>
          Brachiola
         </em>
         species (
         <em>
          Anncaliia vesicularum
         </em>
         and
         <em>
          Anncaliia algerae
         </em>
         ) [
         <a href="#rid9">
          9
         </a>
         ].
         <em>
          Nosema
         </em>
         spp and
         <em>
          Vittaforma corneae
         </em>
         most commonly cause ocular infections. Myositis associated with
         <em>
          Pleistophora
         </em>
         spp,
         <em>
          Trachipleistophora
         </em>
         spp, and
         <em>
          A. algerae
         </em>
         has been described in individual reports [
         <a href="#rid10">
          10-12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of microsporidiosis is poorly understood. The minimal number of microsporidia required to cause human disease is unknown, and no toxins have been described. It is possible that a "carrier state" exists and that reactivation occurs with immunosuppression, although this has not been definitively documented.
        </p>
        <p>
         Intestinal disease is characterized by distortion of the villus architecture, particularly within the small intestine, without a significant inflammatory response. Progressive morphological and functional abnormalities of the small intestine appear to occur as the number of organisms increases [
         <a href="#rid13">
          13
         </a>
         ]. Infection may interfere with intestinal absorption and secretion. In one study of 21 patients with chronic diarrhea or wasting secondary to microsporidiosis, evidence of crypt hyperplasia and a decrease in villous absorptive surface area was demonstrated on jejunal biopsies [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Life cycle
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microsporidia spores typically enter the host via ingestion or inhalation. Once within the intestinal or respiratory tract, the spores are propelled into the host cell by their polar filament, enabling the infective sporoplasm (nucleus) to be injected from the spore into the host cell. Once within the host epithelial cell, proliferation occurs via merogony (binary fission) or schizogony (multiple fission) to form multinucleate plasmodial forms. This is followed by a period of maturation via a process known as sporogony, which involves thickening and development of the spore membranes, further divisions, and finally, formation of new mature spores. These spores ultimately burst out of the infected cell, and the released spores can infect nearby host cells or pass out into the environment. Thus, the spores can complete their life cycle within a single host  (
         <a class="graphic graphic_figure graphicRef78098" href="/z/d/graphic/78098.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microsporidia exist worldwide, although an accurate assessment of their prevalence in the general population has not been established. In one European study of 576 immunocompetent adults, a seroprevalence of 5 to 8 percent was observed; the prevalence of diarrhea was not reported [
         <a href="#rid15">
          15
         </a>
         ]. In one review, the prevalence of microsporidiosis ranged from 1 to 42 percent in individuals with HIV and from 0 to 24 percent in individuals without HIV [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         Most symptomatic infections in humans occur among patients with HIV who are significantly immunocompromised (CD4 &lt;100 cells/microL). The prevalence of infection rises with increased levels of immunosuppression, ranging from 7 to 50 percent in reports of symptomatic patients with diarrhea and/or wasting [
         <a href="#rid17">
          17-22
         </a>
         ]. As an example, in a meta-analysis of 47 studies examining human gastrointestinal microsporidial infections in individuals with HIV found a pooled prevalence of 11.8 percent (95% CI: 10.1-13.4 percent), with higher prevalence seen in low-income countries [
         <a href="#rid23">
          23
         </a>
         ]. In another study of 2652 patients with HIV with diarrhea in Peru, 3 percent were diagnosed with microsporidiosis; risk factors included contact with duck or chicken droppings and poor sanitation [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Patients with HIV may also be asymptomatic. In one study of 106 patients with HIV, 15 percent of patients had evidence of microsporidia on small bowel biopsy, regardless of intestinal symptoms [
         <a href="#rid25">
          25
         </a>
         ]. However, much lower colonization rates have been observed in other reports of patients with HIV but without diarrhea (approximately 2 percent) [
         <a href="#rid17">
          17,26
         </a>
         ].
        </p>
        <p>
         Microsporidia infections have also been described in immunocompromised patients without HIV, such as organ transplant recipients and bone marrow graft recipients [
         <a href="#rid27">
          27-30
         </a>
         ]. Among renal transplant recipients, it is a relatively late-occurring opportunistic infection [
         <a href="#rid31">
          31
         </a>
         ]. Older adult individuals may also be at risk for microsporidiosis; in one report of 47 older adult patients with diarrhea, intestinal microsporidiosis due to
         <em>
          E. bieneusi
         </em>
         was identified in 17 percent of cases by polymerase chain reaction [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Infection can also occur in immunocompetent hosts, largely in the form of diarrheal illness [
         <a href="#rid33">
          33-35
         </a>
         ].
         <em>
          E. intestinalis
         </em>
         has been found in stool samples of travelers with chronic diarrhea, but a pathogenic role has not been definitively demonstrated [
         <a href="#rid36">
          36
         </a>
         ]. A case of ocular microsporidiosis due to
         <em>
          V. corneae
         </em>
         has also been reported in a returned traveler from India [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         It is unknown whether microsporidia infection routinely persists in a latent state or if reactivation occurs during conditions of immune compromise. It is also unknown if persistently infected individuals can transmit infection to others at risk [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transmission of microsporidiosis is not fully understood. Foodborne, waterborne, person-to-person, animal-to-person, vector-borne, and airborne transmission may all be possible [
         <a href="#rid16">
          16,38-42
         </a>
         ]. Microsporidia spores have been detected in urine, feces, and respiratory secretions. Several cases of the transmission of microsporidiosis due to transplanted organs have also been described [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         It has been suggested that microsporidial infection occurs more frequently in patients who drink unboiled water or from untreated streams and rivers, suggesting transmission via water ingestion [
         <a href="#rid43">
          43,44
         </a>
         ]. Foodborne outbreaks of
         <em>
          E. bieneusi
         </em>
         have also been reported [
         <a href="#rid38">
          38,45
         </a>
         ]. Microsporidial keratitis has been described following exposure to floodwaters [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Many animals shed
         <em>
          E. bieneusi
         </em>
         oocysts, including wild living and domestic animals [
         <a href="#rid47">
          47
         </a>
         ], and zoonotic spread is also considered likely [
         <a href="#rid48">
          48,49
         </a>
         ]. Nonhuman primates, pigs, and ruminants are often infected, as are other mammals and birds.
         <em>
          E. intestinalis
         </em>
         has been identified in humans and animals.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations of microsporidiosis vary depending upon the infecting species and the host immune status. Both asymptomatic and symptomatic infections have been described.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Immunocompetent patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microsporidia can cause asymptomatic infection, a self-limited diarrheal illness, or, less commonly, chronic diarrhea [
         <a href="#rid50">
          50,51
         </a>
         ]. Clinical manifestations include watery, nonbloody diarrhea, nausea, diffuse abdominal pain, and fever. Diarrhea tends to be self-limited in immunocompetent patients. The correlation between detection of microsporidia in stool and gastrointestinal symptoms may be transient; microsporidia infection may cause clinical symptoms during the early stages of infection that resolve even though evidence of microsporidia may persist on diagnostic assessment [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         In addition to diarrhea, other extraintestinal manifestations [
         <a href="#rid53">
          53
         </a>
         ] include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ocular infections with superficial punctate keratitis and stromal keratitis associated with eye pain have been described [
         <a href="#rid54">
          54-56
         </a>
         ]. Clinical findings include oval, nonbudding microsporidial spores (which fluoresce bluish-white) and rosette-like clusters of epithelial cells. Risk factors include contact lens use, trauma, eye surgery, use of topical corticosteroids, and exposure to soil, mud, dirty water, or thermal springs [
         <a href="#rid57">
          57,58
         </a>
         ]. Associated organisms include
         <em>
          Microsporidium africanus
         </em>
         ,
         <em>
          Microsporidium ceylonensis
         </em>
         ,
         <em>
          Nosema ocularum
         </em>
         ,
         <em>
          Nosema corneum
         </em>
         (now
         <em>
          V. corneae
         </em>
         ), and
         <em>
          A. algerae
         </em>
         [
         <a href="#rid59">
          59-61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral infections due to
         <em>
          E. cuniculi
         </em>
         have been reportedly rarely in immunocompetent individuals. Manifestations include seizures, headache, and vomiting [
         <a href="#rid62">
          62
         </a>
         ]. Donor-derived
         <em>
          E. cuniculi
         </em>
         infection has also been reported in organ recipients with unexplained encephalitis [
         <a href="#rid63">
          63
         </a>
         ]. One case of pacemaker endocarditis due to
         <em>
          E. cuniculi
         </em>
         has also been reported [
         <a href="#rid64">
          64
         </a>
         ]. An association between
         <em>
          E. cuniculi
         </em>
         and osteolysis of prosthetic hip implants has been reported in a small cohort [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myositis associated with
         <em>
          Pleistophora
         </em>
         spp and
         <em>
          Brachiola algerae
         </em>
         (reclassified as
         <em>
          A. algerae
         </em>
         ) has been described in individual reports [
         <a href="#rid10">
          10,11,66,67
         </a>
         ]. Symptoms include fever, myalgia, weakness, and muscle tenderness.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E.
         </em>
         <em>
          cuniculi
         </em>
         has been reported as a cause of osteolysis in hip periprosthetic tissue and can be associated with instability of the implant [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Patients with HIV
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of microsporidiosis has declined dramatically with the widespread use of antiretroviral therapy. Most microsporidial infections occur in the setting of severe immunodeficiency [
         <a href="#rid68">
          68
         </a>
         ]. In a systematic review and meta-analysis of microsporidiosis in more than 18,000 individuals with HIV, the pooled prevalence of microsporidiosis was 11.8 percent (95% CI 10.1-13.4 percent), with a lower prevalence in high-income countries and a higher prevalence among those with diarrhea [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         <em>
          E. bieneusi
         </em>
         or
         <em>
          E. intestinalis
         </em>
         are most commonly associated with diarrhea, which is typically nonbloody, watery, may be continuous or intermittent, and can be associated with crampy abdominal pain. Patients may also have weight loss, wasting, nausea and vomiting, and malabsorption; fever is rare [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         A number of other disorders associated with the individual microsporidia species have been described:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E. bieneusi
         </em>
         or
         <em>
          E. intestinalis
         </em>
         infection can lead to biliary tract involvement, causing cholangitis or acalculous cholecystitis [
         <a href="#rid70">
          70
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/667.html" rel="external">
          "AIDS cholangiopathy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E. bieneusi
         </em>
         has been identified in nasal and bronchial secretions, although its clinical significance is uncertain [
         <a href="#rid8">
          8,71-75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E. intestinalis
         </em>
         disseminates widely and has been implicated in sinus, respiratory, liver, and renal disease. The renal disease is often asymptomatic, although impaired renal function has been described [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E. hellem
         </em>
         ,
         <em>
          E. cuniculi
         </em>
         , and
         <em>
          Trachipleistophora
         </em>
         species usually cause disseminated infection, including bronchiolitis, pneumonitis, sinusitis, nephritis, cystitis, prostatitis, hepatitis, peritonitis, chronic keratoconjunctivitis, encephalitis, and nodular cutaneous lesions [
         <a href="#rid76">
          76,77
         </a>
         ]. Some patients are asymptomatic. Intestinal infection with
         <em>
          E. cuniculi
         </em>
         is rare [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          T. hominis
         </em>
         , a newly described species, and
         <em>
          Pleistophora
         </em>
         spp have been associated with myositis [
         <a href="#rid12">
          12,79,80
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          V. corneae
         </em>
         has been isolated from urine and sinonasal aspirate in a patient with AIDS [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          E. cuniculi
         </em>
         has been reported to cause central nervous system infection in one patient with AIDS and multifocal hypodense lesions on brain imaging; the diagnosis was established with the detection of microsporidial spores in cerebrospinal fluid, sputum, stool, and urine [
         <a href="#rid82">
          82,83
         </a>
         ]. Disseminated
         <em>
          E. cuniculi
         </em>
         infection has been reported in a renal transplant recipient [
         <a href="#rid84">
          84
         </a>
         ].
         <em>
          Trachipleistophora
         </em>
         species have also been associated with encephalitis and death [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In a retrospective review of 73 patients with HIV and microsporidiosis describing the natural history of infection, 55 percent of patients had persistent diarrhea after six months and 51 percent had weight loss [
         <a href="#rid85">
          85
         </a>
         ]. Symptomatic disease was associated with a high HIV RNA viral load and absence of protease inhibitors from the antiretroviral regimen.
        </p>
        <p class="headingAnchor" id="H7827073">
         <span class="h2">
          Other immunosuppressed patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transplant-associated microsporidiosis (both solid organ and hematopoietic stem cell transplants) and infection in patients with malignancy can occur, leading to a wide range of manifestations [
         <a href="#rid86">
          86-92
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1396.html" rel="external">
          "Infection in the solid organ transplant recipient"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of microsporidiosis consists of microscopic or genomic detection of the spores in stool, body fluids, or tissue specimens. The spores are typically oval and 1 to 2 microns in diameter. Endoscopic biopsy is not more sensitive than stool examination because infection can be patchy [
         <a href="#rid71">
          71,93
         </a>
         ].
        </p>
        <p>
         For microscopic diagnosis, the laboratory should be alerted to the potential diagnosis, and specific stains for microsporidia should be requested since routine examination for ova and parasites does not usually detect microsporidia spores. Fecal leukocytes and blood are usually absent since microsporidia infection is not associated with a significant inflammation. When present, these findings should raise suspicion for coinfection with another organism.
        </p>
        <p>
         Light microscopy with a modified trichrome stain is often used for diagnosis. This technique stains microsporidia spores pink against a blue-green background; it can be used on stool, urine, mucus, or tissue specimens  (
         <a class="graphic graphic_figure graphicRef78496" href="/z/d/graphic/78496.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid94">
          94,95
         </a>
         ]. Other techniques include serologic assays (which detect immunoglobulin [Ig]M and IgG antimicrosporidial antibodies), tissue culture, and indirect immunofluorescence [
         <a href="#rid96">
          96-102
         </a>
         ]. Fluorescent techniques including Uvitex 2B, Calcofluor White M2R, the FungiFluor Kit, and Fungiqual A are also available and have similar sensitivity and specificity to the modified trichrome stain [
         <a href="#rid93">
          93,103,104
         </a>
         ]. These stains have a number of advantages compared with other methods because they can be performed rapidly, are equally effective on unfixed or formalin-fixed specimens, and can detect spores in stool, intestinal fluid, biopsy imprints, and paraffin biopsy sections [
         <a href="#rid96">
          96,97
         </a>
         ]. However, species identification is not possible.
        </p>
        <p>
         Transmission electron microscopy is also used for microscopic detection of microsporidia and traditionally has been the primary method for species identification [
         <a href="#rid82">
          82
         </a>
         ]. Alternatively, classification can be based on molecular sequencing.
        </p>
        <p>
         Polymerase chain reaction (PCR) assays are increasingly being used for diagnosis, simultaneously enabling detection, species identification, and genomic characterization of the microsporidial infection [
         <a href="#rid39">
          39,105-111
         </a>
         ]. PCR-based tests have been used with both tissue biopsy specimens and body fluids, and have been shown to be able to detect 100 to 1,000 spores/mL in clinical samples [
         <a href="#rid2">
          2
         </a>
         ]. In one study of intestinal microsporidiosis, PCR was 100 percent sensitive and 97.9 percent specific, trichrome staining was 100 percent specific and 64 percent sensitive, and calcofluor staining was 80 percent sensitive and 82 percent specific [
         <a href="#rid112">
          112
         </a>
         ]. Indirect immunofluorescence using monoclonal antibodies to
         <em>
          Encephalitozoon
         </em>
         spp and to
         <em>
          E. bieneusi
         </em>
         are becoming increasingly available and are simplifying detection of microsporidia in clinical specimens [
         <a href="#rid113">
          113-115
         </a>
         ]. A loop-mediated isothermal amplification assay has also been developed to detect
         <em>
          E. bieneusi
         </em>
         DNA from human fecal specimens [
         <a href="#rid116">
          116
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4035437075">
         <span class="h2">
          Test characteristics
         </span>
         <span class="headingEndMark">
          —
         </span>
         The accuracy of the above techniques depends in part upon the site and intensity of infection. One study evaluating sensitivity and specificity (with electron microscopy as the gold standard) noted the following: modified trichrome stain (sensitivity and specificity of 100 and 83 percent, respectively), calcofluor white stain (sensitivity and specificity of 100 and 77 percent, respectively), and indirect immunofluorescent stain (sensitivity and specificity of 83 and 96 percent, respectively) [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p>
         In another study, stool samples were tested via modified trichrome stain, PCR-restriction fragment length polymorphism, and immunofluorescence assay (IFA). Considering modified trichrome stain as the gold standard, the sensitivity and specificity of IFA were 100 and 99.4 percent, respectively. Considering PCR as the gold standard, sensitivity and specificity of IFA were 95.2 and 100 percent, respectively [
         <a href="#rid117">
          117
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H20620119">
         <span class="h2">
          Gastrointestinal infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          Albendazole
         </a>
         is effective against most microsporidia species, particularly
         <em>
          Encephalitozoon
         </em>
         infections, but has minimal efficacy against
         <em>
          E. bieneusi
         </em>
         (
         <a class="graphic graphic_table graphicRef54051" href="/z/d/graphic/54051.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid118">
          118-122
         </a>
         ]. The duration of therapy depends on the host immune status and whether the infection is localized or disseminated [
         <a href="#rid123">
          123
         </a>
         ]. In immunocompromised patients with disseminated infection, the usual treatment is three weeks (or between two and four weeks) of albendazole (400 mg orally with fatty meal twice daily) [
         <a href="#rid124">
          124,125
         </a>
         ].
        </p>
        <p>
         Immunocompetent hosts can receive shorter courses of therapy and may even resolve their symptoms with no therapy at all. In a randomized trial including 200 immunocompetent children in Costa Rica hospitalized with subacute diarrhea due to microsporidiosis,
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          albendazole
         </a>
         (15 mg/kg/day divided twice daily [maximum 400 mg/dose] for seven days) was more effective than placebo in improving the clinical manifestations and decreasing the duration of illness [
         <a href="#rid126">
          126
         </a>
         ].
        </p>
        <p>
         Because
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          albendazole
         </a>
         does not reliably cure
         <em>
          E. bieneusi
         </em>
         infections, many other agents have been tried including
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         , sparfloxacin, quinacrine, sulfa drugs,
         <a class="drug drug_general" data-topicid="8957" href="/z/d/drug information/8957.html" rel="external">
          atovaquone
         </a>
         , furazolidone,
         <a class="drug drug_general" data-topicid="10105" href="/z/d/drug information/10105.html" rel="external">
          nitazoxanide
         </a>
         ,
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9714" href="/z/d/drug information/9714.html" rel="external">
          octreotide
         </a>
         , and
         <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">
          paromomycin
         </a>
         . None of these agents has consistently or effectively eradicated the infection; further study is needed.
        </p>
        <p>
         Along with specific therapy for microsporidiosis, treatment of immune suppression is critically important in patients with HIV, since restoration of immunity has been associated with clinical and microbiological cure [
         <a href="#rid127">
          127-129
         </a>
         ]. Clearance of microsporidial infections has even been reported with antiretroviral therapy alone [
         <a href="#rid130">
          130,131
         </a>
         ]. Dietary supplementation is also helpful, particularly in patients who have had weight loss [
         <a href="#rid132">
          132
         </a>
         ].
        </p>
        <p>
         For treatment of
         <em>
          E. bieneusi
         </em>
         infection, systemic fumagillin (60 mg/day orally in three divided doses for 14 days) has been tried with some success [
         <a href="#rid125">
          125,133,134
         </a>
         ]. In one small dose-response study of fumagillin in patients with HIV with
         <em>
          E. bieneusi
         </em>
         infection, the highest dose of 60 mg/day was associated with clearance of the organism in 72 percent of cases [
         <a href="#rid133">
          133
         </a>
         ]. The majority of patients in the lower-dose groups had transient clearance from stools but all relapsed within one year. Fumagillin may also be active in other immunosuppressed hosts. A randomized, double-blind study in 12 patients (10 with HIV and 2 posttransplantation) documented clearance of the organism in all patients who received fumagillin and in none of patients receiving placebo; the six placebo recipients subsequently cleared the organism with open-label fumagillin [
         <a href="#rid134">
          134
         </a>
         ]. In a report of 10 cases of
         <em>
          E. bieneusi
         </em>
         in renal transplant patients who were treated with fumagillin, all patients responded well clinically and all cleared the microsporidial spores from their stools [
         <a href="#rid31">
          31
         </a>
         ]. Fumagillin was effective in a pediatric liver-kidney transplant patient with intestinal disease [
         <a href="#rid135">
          135
         </a>
         ]. Fumagillin was curative for
         <em>
          E. bieneusi
         </em>
         microsporidiosis in two allogeneic hematopoietic stem cell transplant recipients [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Fumagillin can cause dose-related bone marrow toxicity. Among 166 immunosuppressed patients (mainly transplant recipients) treated with fumagillin in France, adverse events occurred in 31 percent, mainly thrombocytopenia (18 percent), neutropenia (5.4 percent), anemia (3 percent), and hepatitis (3 percent); two hemorrhagic events occurred with one death, and one case of liver failure occurred. Neurological toxicity was also seen. However, the agent had high efficacy (negative stool examinations at the end of treatment was seen in 94 percent of patients), and only three parasite relapses were documented [
         <a href="#rid136">
          136
         </a>
         ]. In addition, abdominal pain, diarrhea, vomiting, and hyperlipasemia have been noted with the use of fumagillin. These adverse effects have limited the clinical use of the drug.
        </p>
        <p>
         Other agents being studied in vivo against microsporidia include polyamines and fluoroquinolones, but clinical data are lacking [
         <a href="#rid137">
          137
         </a>
         ]. Limited data suggest that
         <a class="drug drug_general" data-topicid="10105" href="/z/d/drug information/10105.html" rel="external">
          nitazoxanide
         </a>
         (1 g twice daily) for 60 days may also be effective for the treatment of
         <em>
          E. bieneusi
         </em>
         infections in patients with AIDS [
         <a href="#rid138">
          138
         </a>
         ] and other immunosuppressive conditions [
         <a href="#rid139">
          139
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20620126">
         <span class="h2">
          Ocular infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ocular keratoconjunctivitis due to microsporidia are often treated with topical Fumidil B (fumagillin bicyclohexylammonium) in
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         (to achieve a concentration of 70 mg/mL of fumagillin) [
         <a href="#rid122">
          122,140
         </a>
         ]. In patients with HIV, lesions due to
         <em>
          E. hellem,
         </em>
         <em>
          E. cuniculi
         </em>
         ,
         <em>
          E. intestinalis
         </em>
         ,
         <em>
          E. bieneusi
         </em>
         , and
         <em>
          V. corneae
         </em>
         generally respond to this regimen. The concomitant use of
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          albendazole
         </a>
         is often warranted, particularly in patients with ocular infections who have evidence of systemic involvement. Topical
         <a class="drug drug_general" data-topicid="10118" href="/z/d/drug information/10118.html" rel="external">
          voriconazole
         </a>
         (1%) has been reported to be effective for treatment of microsporidial keratitis [
         <a href="#rid141">
          141-143
         </a>
         ], and success has also been reported with topical fluoroquinolones [
         <a href="#rid144">
          144,145
         </a>
         ]; further trials are needed. For patients with stromal keratitis, epithelial debridement or early surgical keratoplasty may be needed [
         <a href="#rid37">
          37,146
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          Itraconazole
         </a>
         has also been used in the treatment of ocular microsporidiosis (especially superficial keratoconjunctivitis) due to E
         <em>
          ncephalitozoon
         </em>
         spp; experience with this agent is limited [
         <a href="#rid123">
          123
         </a>
         ]. In cases not responsive to medical therapy, keratoplasty and debulking by corneal scraping has been tried [
         <a href="#rid147">
          147
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H885865781">
         <span class="h2">
          Pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal approach to management in pregnancy is uncertain. Safety data of
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          albendazole
         </a>
         and
         <a class="drug drug_general" data-topicid="10105" href="/z/d/drug information/10105.html" rel="external">
          nitazoxanide
         </a>
         in pregnancy are limited. Minimizing immunosuppression is an important component of management.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific measures important in preventing infection are not known since the sources of infection are not fully understood. Attention to personal hygiene is probably the most important factor. Boiled and/or bottled water may also be helpful for immunosuppressed patients, but the relative importance of tap water as a source of infection is still unknown. No vaccine is available.
        </p>
        <p class="headingAnchor" id="H116961478">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111612.html" rel="external">
          "Society guideline links: Opportunistic infections in adults with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10139391">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology –
         </strong>
         Microsporidia are intracellular spore-forming organisms that are ubiquitous in the environment and can infect a wide range of vertebrate and invertebrate hosts. Seventeen different species have been reported in humans, many of which were discovered as opportunistic infections in association with the AIDS epidemic  (
         <a class="graphic graphic_table graphicRef70473" href="/z/d/graphic/70473.html" rel="external">
          table 1
         </a>
         ). The most common species causing infection in humans is
         <em>
          Enterocytozoon bieneusi
         </em>
         , followed by the
         <em>
          Encephalitozoon
         </em>
         species, particularly
         <em>
          Encephalitozoon intestinalis
         </em>
         . (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology –
         </strong>
         Transmission of microsporidiosis is not fully understood. Microsporidia spores typically enter the host via ingestion or inhalation. Most symptomatic infections in humans occur among patients with HIV who are significantly immunocompromised (CD4 &lt;100 cells/microL) or other immunocompromised individuals (such as organ transplant recipients). Microsporidiosis can also occur in immunocompetent individuals. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations –
         </strong>
         Clinical manifestations include watery, nonbloody diarrhea, nausea, diffuse abdominal pain, and fever. Among immunocompetent and immunosuppressed individuals, other manifestations include ocular infection, cerebral infection, and myositis. In addition, a variety of other manifestations can occur in the setting of HIV infection. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis –
         </strong>
         The diagnosis of microsporidiosis consists of microscopic detection of the spores in stool, body fluids, or tissue specimens. Light microscopy with a modified trichrome stain demonstrates pink microsporidia spores against a blue-green background  (
         <a class="graphic graphic_figure graphicRef78496" href="/z/d/graphic/78496.html" rel="external">
          figure 1
         </a>
         ). The laboratory should be alerted to the potential diagnosis, and specific stains for microsporidia should be requested since routine examination for ova and parasites does not usually detect microsporidia spores. Other assays have also been described. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment –
         </strong>
         We suggest
         <a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">
          albendazole
         </a>
         (400 mg orally twice daily for two to four weeks) for treatment of intestinal microsporidiosis due to
         <em>
          E. intestinalis
         </em>
         and for treatment of disseminated microsporidiosis  (
         <a class="graphic graphic_table graphicRef54051" href="/z/d/graphic/54051.html" rel="external">
          table 2
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). The optimal approach for treatment of intestinal infection due to
         <em>
          E. bieneusi
         </em>
         or for treatment of ocular infection is uncertain; fumagillin may be effective though further study is needed. Reversal of immune suppression whenever possible is also important. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Didier ES, Weiss LM. Microsporidiosis: current status. Curr Opin Infect Dis 2006; 19:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han B, Pan G, Weiss LM. Microsporidiosis in Humans. Clin Microbiol Rev 2021; 34:e0001020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heyworth MF. Genetic aspects and environmental sources of microsporidia that infect the human gastrointestinal tract. Trans R Soc Trop Med Hyg 2017; 111:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li W, Feng Y, Santin M. Host Specificity of Enterocytozoon bieneusi and Public Health Implications. Trends Parasitol 2019; 35:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li W, Feng Y, Zhang L, Xiao L. Potential impacts of host specificity on zoonotic or interspecies transmission of Enterocytozoon bieneusi. Infect Genet Evol 2019; 75:104033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mo L, Drancourt M. Antigenic diversity of Encephalitozoon hellem demonstrated by subspecies-specific monoclonal antibodies. J Eukaryot Microbiol 2002; 49:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao L, Li L, Moura H, et al. Genotyping Encephalitozoon hellem isolates by analysis of the polar tube protein gene. J Clin Microbiol 2001; 39:2191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Botterel F, Minozzi C, Vittecoq D, Bourée P. Pulmonary localization of Enterocytozoon bieneusi in an AIDS patient: case report and review. J Clin Microbiol 2002; 40:4800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 2006; 42:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coyle CM, Weiss LM, Rhodes LV 3rd, et al. Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N Engl J Med 2004; 351:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cali A, Takvorian PM. Ultrastructure and development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual. J Eukaryot Microbiol 2003; 50:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curry A, Beeching NJ, Gilbert JD, et al. Trachipleistophora hominis infection in the myocardium and skeletal muscle of a patient with AIDS. J Infect 2005; 51:e139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orenstein JM, Chiang J, Steinberg W, et al. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: a report of 20 cases. Hum Pathol 1990; 21:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batman PA, Kotler DP, Kapembwa MS, et al. HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa. AIDS 2007; 21:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Gool T, Vetter JC, Weinmayr B, et al. High seroprevalence of Encephalitozoon species in immunocompetent subjects. J Infect Dis 1997; 175:1020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anane S, Attouchi H. Microsporidiosis: epidemiology, clinical data and therapy. Gastroenterol Clin Biol 2010; 34:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotler DP, Orenstein JM. Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation. Am J Gastroenterol 1994; 89:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ, et al. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 1991; 337:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotler DP, Francisco A, Clayton F, et al. Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med 1990; 113:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Framm SR, Soave R. Agents of diarrhea. Med Clin North Am 1997; 81:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drobniewski F, Kelly P, Carew A, et al. Human microsporidiosis in African AIDS patients with chronic diarrhea. J Infect Dis 1995; 171:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobottka I, Schwartz DA, Schottelius J, et al. Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: a prospective coprodiagnostic study. Clin Infect Dis 1998; 26:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang ZD, Liu Q, Liu HH, et al. Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasit Vectors 2018; 11:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bern C, Kawai V, Vargas D, et al. The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis 2005; 191:1658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabeneck L, Gyorkey F, Genta RM, et al. The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann Intern Med 1993; 119:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coyle CM, Wittner M, Kotler DP, et al. Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin Infect Dis 1996; 23:1002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber R, Bryan RT. Microsporidial infections in immunodeficient and immunocompetent patients. Clin Infect Dis 1994; 19:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gumbo T, Hobbs RE, Carlyn C, et al. Microsporidia infection in transplant patients. Transplantation 1999; 67:482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metge S, Van Nhieu JT, Dahmane D, et al. A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient. Eur J Clin Microbiol Infect Dis 2000; 19:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanternier F, Boutboul D, Menotti J, et al. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review. Transpl Infect Dis 2009; 11:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Champion L, Durrbach A, Lang P, et al. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Am J Transplant 2010; 10:1925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lores B, López-Miragaya I, Arias C, et al. Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus--negative patients from Vigo, Spain. Clin Infect Dis 2002; 34:918.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fournier S, Liguory O, Garrait V, et al. Microsporidiosis due to Enterocytozoon bieneusi infection as a possible cause of traveller's diarrhea. Eur J Clin Microbiol Infect Dis 1998; 17:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bryan RT, Weber R, Schwartz DA. Microsporidiosis in patients who are not infected with human immunodeficiency virus. Clin Infect Dis 1997; 24:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López-Vélez R, Turrientes MC, Garrón C, et al. Microsporidiosis in travelers with diarrhea from the tropics. J Travel Med 1999; 6:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raynaud L, Delbac F, Broussolle V, et al. Identification of Encephalitozoon intestinalis in travelers with chronic diarrhea by specific PCR amplification. J Clin Microbiol 1998; 36:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leroy J, Cornu M, Deleplancque AS, et al. Case Report: Ocular Microsporidiosis: Case in a Patient Returning from India and Review of the Literature. Am J Trop Med Hyg 2018; 99:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Decraene V, Lebbad M, Botero-Kleiven S, et al. First reported foodborne outbreak associated with microsporidia, Sweden, October 2009. Epidemiol Infect 2012; 140:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Didier ES, Stovall ME, Green LC, et al. Epidemiology of microsporidiosis: sources and modes of transmission. Vet Parasitol 2004; 126:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotte L, Rabodonirina M, Chapuis F, et al. Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis 1999; 180:2003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slodkowicz-Kowalska A, Graczyk TK, Tamang L, et al. Microsporidian species known to infect humans are present in aquatic birds: implications for transmission via water? Appl Environ Microbiol 2006; 72:4540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stentiford GD, Becnel -J, Weiss LM, et al. Microsporidia - Emergent Pathogens in the Global Food Chain. Trends Parasitol 2016; 32:336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu H, Jiang Z, Yuan Z, et al. Infection by and genotype characteristics of Enterocytozoon bieneusi in HIV/AIDS patients from Guangxi Zhuang autonomous region, China. BMC Infect Dis 2017; 17:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akinbo FO, Okaka CE, Omoregie R, et al. Molecular epidemiologic characterization of Enterocytozoon bieneusi in HIV-infected persons in Benin City, Nigeria. Am J Trop Med Hyg 2012; 86:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michlmayr D, Alves de Sousa L, Müller L, et al. Incubation Period, Spore Shedding Duration, and Symptoms of Enterocytozoon bieneusi Genotype C Infection in a Foodborne Outbreak in Denmark, 2020. Clin Infect Dis 2022; 75:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malik S, Ishaq M, Nayyar S, Humayun S. Microsporidial Keratitis - First Case Series of a Rare Pathogen in the Wake of Flood Disasters of 2022 in Pakistan. J Coll Physicians Surg Pak 2022; 32:SS165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leśniańska K, Perec-Matysiak A. Wildlife as an environmental reservoir of Enterocytozoon bieneusi (Microsporidia) – analyses of data based on molecular methods. Ann Parasitol 2017; 63:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Javanmard E, Mirjalali H, Niyyati M, et al. Molecular and phylogenetic evidences of dispersion of human-infecting microsporidia to vegetable farms via irrigation with treated wastewater: One-year follow up. Int J Hyg Environ Health 2018; 221:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ding S, Huang W, Qin Q, et al. Genotype Identification and Phylogenetic Analysis of Enterocytozoon bieneusi Isolates from Stool Samples of Diarrheic Children. J Parasitol 2018; 104:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wanke CA, DeGirolami P, Federman M. Enterocytozoon bieneusi infection and diarrheal disease in patients who were not infected with human immunodeficiency virus: case report and review. Clin Infect Dis 1996; 23:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gainzarain JC, Canut A, Lozano M, et al. Detection of Enterocytozoon bieneusi in two human immunodeficiency virus-negative patients with chronic diarrhea by polymerase chain reaction in duodenal biopsy specimens and review. Clin Infect Dis 1998; 27:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wichro E, Hoelzl D, Krause R, et al. Microsporidiosis in travel-associated chronic diarrhea in immune-competent patients. Am J Trop Med Hyg 2005; 73:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramanan P, Pritt BS. Extraintestinal microsporidiosis. J Clin Microbiol 2014; 52:3839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis NL, Francis IC, Hawkins GS, Coroneo MT. Bilateral microsporidial keratoconjunctivitis in an immunocompetent non-contact lens wearer. Cornea 2003; 22:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan CM, Theng JT, Li L, Tan DT. Microsporidial keratoconjunctivitis in healthy individuals: a case series. Ophthalmology 2003; 110:1420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malhotra C, Jain AK, Kaur S, et al. In vivo confocal microscopic characteristics of microsporidial keratoconjunctivitis in immunocompetent adults. Br J Ophthalmol 2017; 101:1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fan NW, Wu CC, Chen TL, et al. Microsporidial keratitis in patients with hot springs exposure. J Clin Microbiol 2012; 50:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwok AK, Tong JM, Tang BS, et al. Outbreak of microsporidial keratoconjunctivitis with rugby sport due to soil exposure. Eye (Lond) 2013; 27:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Visvesvara GS, Belloso M, Moura H, et al. Isolation of Nosema algerae from the cornea of an immunocompetent patient. J Eukaryot Microbiol 1999; 46:10S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashton N, Wirasinha PA. Encephalitozoonosis (nosematosis) of the cornea. Br J Ophthalmol 1973; 57:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cali A, Meisler DM, Lowder CY, et al. Corneal microsporidioses: characterization and identification. J Protozool 1991; 38:215S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergquist NR, Stintzing G, Smedman L, et al. Diagnosis of encephalitozoonosis in man by serological tests. Br Med J (Clin Res Ed) 1984; 288:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith RM, Muehlenbachs A, Schaenmann J, et al. Three Cases of Neurologic Syndrome Caused by Donor-Derived Microsporidiosis. Emerg Infect Dis 2017; 23:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Filho MM, Ribeiro HB, Paula LJ, et al. Images in cardiovascular medicine. Endocarditis secondary to microsporidia: giant vegetation in a pacemaker user. Circulation 2009; 119:e386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kicia M, Wesolowska M, Kopacz Z, et al. Disseminated Infection of Encephalitozoon cuniculi Associated With Osteolysis of Hip Periprosthetic Tissue. Clin Infect Dis 2018; 67:1228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watts MR, Chan RC, Cheong EY, et al. Anncaliia algerae microsporidial myositis. Emerg Infect Dis 2014; 20:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel AK, Patel KK, Chickabasaviah YT, et al. Microsporidial polymyositis in human immunodeficiency virus-infected patients, a rare life-threatening opportunistic infection: clinical suspicion, diagnosis, and management in resource-limited settings. Muscle Nerve 2015; 51:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dore GJ, Marriott DJ, Hing MC, et al. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. Clin Infect Dis 1995; 21:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agholi M, Hatam GR, Motazedian MH. HIV/AIDS-associated opportunistic protozoal diarrhea. AIDS Res Hum Retroviruses 2013; 29:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993; 328:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leder K, Ryan N, Spelman D, Crowe SM. Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature. Scand J Infect Dis 1998; 30:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber R, Kuster H, Keller R, et al. Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1992; 146:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           del Aguila C, Lopez-Velez R, Fenoy S, et al. Identification of Enterocytozoon bieneusi spores in respiratory samples from an AIDS patient with a 2-year history of intestinal microsporidiosis. J Clin Microbiol 1997; 35:1862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Georges E, Rabaud C, Amiel C, et al. Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. J Infect 1998; 36:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kicia M, Sędzimirska M, Sak B, et al. Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient. Int J Infect Dis 2018; 77:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz DA, Visvesvara GS, Leitch GJ, et al. Pathology of symptomatic microsporidial (Encephalitozoon hellem) bronchiolitis in the acquired immunodeficiency syndrome: a new respiratory pathogen diagnosed from lung biopsy, bronchoalveolar lavage, sputum, and tissue culture. Hum Pathol 1993; 24:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scaglia M, Gatti S, Sacchi L, et al. Asymptomatic respiratory tract microsporidiosis due to Encephalitozoon hellem in three patients with AIDS. Clin Infect Dis 1998; 26:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franzen C, Schwartz DA, Visvesvara GS, et al. Immunologically confirmed disseminated, asymptomatic Encephalitozoon cuniculi infection of the gastrointestinal tract in a patient with AIDS. Clin Infect Dis 1995; 21:1480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollister WS, Canning EU, Weidner E, et al. Development and ultrastructure of Trachipleistophora hominis n.g., n.sp. after in vitro isolation from an AIDS patient and inoculation into athymic mice. Parasitology 1996; 112 ( Pt 1):143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siripaitoon P, Seatamanoch N, Brownell N, et al. Case Report: First Report of Disseminated Trachipleistophora hominis Infection in an AIDS Patient from Thailand. Am J Trop Med Hyg 2021; 105:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deplazes P, Mathis A, van Saanen M, et al. Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDS. Clin Infect Dis 1998; 27:1521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 2006; 42:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber R, Deplazes P, Flepp M, et al. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med 1997; 336:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagpal A, Pritt BS, Lorenz EC, et al. Disseminated microsporidiosis in a renal transplant recipient: case report and review of the literature. Transpl Infect Dis 2013; 15:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dascomb K, Clark R, Aberg J, et al. Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus. J Clin Microbiol 1999; 37:3421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hocevar SN, Paddock CD, Spak CW, et al. Microsporidiosis acquired through solid organ transplantation: a public health investigation. Ann Intern Med 2014; 160:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bukreyeva I, Angoulvant A, Bendib I, et al. Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin. Emerg Infect Dis 2017; 23:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ladapo TA, Nourse P, Pillay K, et al. Microsporidiosis in pediatric renal transplant patients in Cape Town, South Africa: two case reports. Pediatr Transplant 2014; 18:E220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown M, Longano A, Dendle C, et al. Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: A case report and review of the literature. Transpl Infect Dis 2018; 20:e12888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghoyounchi R, Mahami-Oskouei M, Rezamand A, et al. Molecular Phylodiagnosis of Enterocytozoon bieneusi and Encephalitozoon intestinalis in Children with Cancer: Microsporidia in Malignancies as an Emerging Opportunistic Infection. Acta Parasitol 2019; 64:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumond C, Aulagnon F, Etienne I, et al. Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry. Transpl Infect Dis 2021; 23:e13708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumortier J, Radenne S, Kamar N, et al. Microsporidiosis after liver transplantation: A French nationwide retrospective study. Transpl Infect Dis 2021; 23:e13665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeGirolami PC, Ezratty CR, Desai G, et al. Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains. J Clin Microbiol 1995; 33:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryan NJ, Sutherland G, Coughlan K, et al. A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol 1993; 31:3264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matos O, Lobo ML, Gonçalves L, Antunes F. Diagnostic use of 3 techniques for identification of microsporidian spores among AIDS patients in Portugal. Scand J Infect Dis 2002; 34:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fedorko DP, Hijazi YM. Application of molecular techniques to the diagnosis of microsporidial infection. Emerg Infect Dis 1996; 2:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Gool T, Snijders F, Reiss P, et al. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol 1993; 46:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss LM, Vossbrinck CR. Microsporidiosis: molecular and diagnostic aspects. Adv Parasitol 1998; 40:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Müller A, Stellermann K, Hartmann P, et al. A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens. Clin Diagn Lab Immunol 1999; 6:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liguory O, David F, Sarfati C, et al. Diagnosis of infections caused by Enterocytozoon bieneusi and Encephalitozoon intestinalis using polymerase chain reaction in stool specimens. AIDS 1997; 11:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franzen C, Müller A. Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clin Microbiol Rev 1999; 12:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Didier ES, Orenstein JM, Aldras A, et al. Comparison of three staining methods for detecting microsporidia in fluids. J Clin Microbiol 1995; 33:3138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber R, Bryan RT, Owen RL, et al. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N Engl J Med 1992; 326:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ignatius R, Henschel S, Liesenfeld O, et al. Comparative evaluation of modified trichrome and Uvitex 2B stains for detection of low numbers of microsporidial spores in stool specimens. J Clin Microbiol 1997; 35:2266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conners MS, Gibler TS, Van Gelder RN. Diagnosis of microsporidia keratitis by polymerase chain reaction. Arch Ophthalmol 2004; 122:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fedorko DP, Nelson NA, Didier ES, et al. Speciation of human microsporidia by polymerase chain reaction single-strand conformation polymorphism. Am J Trop Med Hyg 2001; 65:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hester JD, Varma M, Bobst AM, et al. Species-specific detection of three human-pathogenic microsporidial species from the genus Encephalitozoon via fluorogenic 5' nuclease PCR assays. Mol Cell Probes 2002; 16:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menotti J, Cassinat B, Porcher R, et al. Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis. J Infect Dis 2003; 187:1469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subrungruang I, Mungthin M, Chavalitshewinkoon-Petmitr P, et al. Evaluation of DNA extraction and PCR methods for detection of Enterocytozoon bienuesi in stool specimens. J Clin Microbiol 2004; 42:3490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolk DM, Schneider SK, Wengenack NL, et al. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. J Clin Microbiol 2002; 40:3922.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polley SD, Boadi S, Watson J, et al. Detection and species identification of microsporidial infections using SYBR Green real-time PCR. J Med Microbiol 2011; 60:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saigal K, Khurana S, Sharma A, et al. Comparison of staining techniques and multiplex nested PCR for diagnosis of intestinal microsporidiosis. Diagn Microbiol Infect Dis 2013; 77:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mo L, Drancourt M. Monoclonal antibodies for specific detection of Encephalitozoon cuniculi. Clin Diagn Lab Immunol 2004; 11:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheoran AS, Feng X, Singh I, et al. Monoclonal antibodies against Enterocytozoon bieneusi of human origin. Clin Diagn Lab Immunol 2005; 12:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Mekhlafi MA, Fatmah MS, Anisah N, et al. Species identification of intestinal microsporidia using immunofluorescence antibody assays. Southeast Asian J Trop Med Public Health 2011; 42:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nur Su'aidah Nasarudin S, Shazalina Zainudin N, Bernadus M, et al. Loop-mediated isothermal amplification for rapid molecular detection of Enterocytozoon bieneusi in faecal specimens. J Med Microbiol 2015; 64:1329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghoshal U, Khanduja S, Pant P, Ghoshal UC. Evaluation of Immunoflourescence antibody assay for the detection of Enterocytozoon bieneusi and Encephalitozoon intestinalis. Parasitol Res 2016; 115:3709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Molina JM, Chastang C, Goguel J, et al. Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial. J Infect Dis 1998; 177:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dionisio D, Manneschi LI, Di Lollo S, et al. Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. J Clin Pathol 1998; 51:731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maggi P, Larocca AM, Quarto M, et al. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2000; 19:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross U. Treatment of microsporidiosis including albendazole. Parasitol Res 2003; 90 Supp 1:S14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costa SF, Weiss LM. Drug treatment of microsporidiosis. Drug Resist Updat 2000; 3:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           La Hoz RM, Morris MI, AST Infectious Diseases Community of Practice. Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13618.
          </a>
         </li>
         <li class="breakAll">
          Drugs for Parasitic Infections, 3rd ed, The Medical Letter, New Rochelle, NY 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tremoulet AH, Avila-Aguero ML, París MM, et al. Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. Pediatr Infect Dis J 2004; 23:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goguel J, Katlama C, Sarfati C, et al. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. AIDS 1997; 11:1658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carr A, Marriott D, Field A, et al. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conteas CN, Berlin OG, Ash LR, Pruthi JS. Therapy for human gastrointestinal microsporidiosis. Am J Trop Med Hyg 2000; 63:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conteas CN, Berlin OG, Speck CE, et al. Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy. Am J Trop Med Hyg 1998; 58:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miao YM, Awad-El-Kariem FM, Franzen C, et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asmuth DM, DeGirolami PC, Federman M, et al. Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis 1994; 18:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Molina JM, Goguel J, Sarfati C, et al. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA. AIDS 2000; 14:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Molina JM, Tourneur M, Sarfati C, et al. Fumagillin treatment of intestinal microsporidiosis. N Engl J Med 2002; 346:1963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desoubeaux G, Maakaroun-Vermesse Z, Lier C, et al. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant. Transpl Infect Dis 2013; 15:E250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maillard A, Scemla A, Laffy B, et al. Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study. J Antimicrob Chemother 2021; 76:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Didier ES, Maddry JA, Brindley PJ, et al. Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 2005; 3:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bicart-Sée A, Massip P, Linas MD, Datry A. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Antimicrob Agents Chemother 2000; 44:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou L, Guan Z, Chen C, et al. The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report. Front Cell Infect Microbiol 2022; 12:1072463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khandelwal SS, Woodward MA, Hall T, et al. Treatment of microsporidia keratitis with topical voriconazole monotherapy. Arch Ophthalmol 2011; 129:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal P, Coc IR, Navon SE. Importance of clinical signs leading to the diagnosis in a case of microbiological smear negative ocular microsporidiosis. BMJ Case Rep 2019; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma KK, Kinde B, Doan T, et al. Dual Molecular Diagnosis of Microsporidia (Encephalitozoon hellem) Keratoconjunctivitis in an Immunocompetent Adult. Cornea 2021; 40:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loh RS, Chan CM, Ti SE, et al. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology 2009; 116:2348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thanathanee O, Athikulwongse R, Anutarapongpan O, et al. Clinical Features, Risk Factors, and Treatments of Microsporidial Epithelial Keratitis. Semin Ophthalmol 2016; 31:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghavan A, Raja DR, Venkatapathy N, Rammohan R. A case of stromal microsporidiosis: medical strategies employed for successful resolution. BMJ Case Rep 2022; 15.
          </a>
         </li>
         <li class="breakAll">
          Weiss LM, Schwartz DA. Microsporidiosis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.714.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5731 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16940873" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Microsporidiosis: current status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34190570" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Microsporidiosis in Humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28339881" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Genetic aspects and environmental sources of microsporidia that infect the human gastrointestinal tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31076351" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Host Specificity of Enterocytozoon bieneusi and Public Health Implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31494271" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Potential impacts of host specificity on zoonotic or interspecies transmission of Enterocytozoon bieneusi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12120990" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Antigenic diversity of Encephalitozoon hellem demonstrated by subspecies-specific monoclonal antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11376056" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Genotyping Encephalitozoon hellem isolates by analysis of the polar tube protein gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12454201" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Pulmonary localization of Enterocytozoon bieneusi in an AIDS patient: case report and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16323101" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15229306" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12744518" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ultrastructure and development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16230193" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Trachipleistophora hominis infection in the myocardium and skeletal muscle of a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1692561" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: a report of 20 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17301561" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9086174" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : High seroprevalence of Encephalitozoon species in immunocompetent subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20702053" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Microsporidiosis: epidemiology, clinical data and therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7942725" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1672978" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2386337" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Small intestinal injury and parasitic diseases in AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9093236" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Agents of diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7844408" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Human microsporidiosis in African AIDS patients with chronic diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9502473" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: a prospective coprodiagnostic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29316950" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15838792" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8215001" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8922793" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7811872" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Microsporidial infections in immunodeficient and immunocompetent patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10030299" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Microsporidia infection in transplant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10795597" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18803616" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20636462" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11880956" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus--negative patients from Vigo, Spain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9865995" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Microsporidiosis due to Enterocytozoon bieneusi infection as a possible cause of traveller's diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9114227" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Microsporidiosis in patients who are not infected with human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10575169" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Microsporidiosis in travelers with diarrhea from the tropics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9431916" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Identification of Encephalitozoon intestinalis in travelers with chronic diarrhea by specific PCR amplification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29692301" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Case Report: Ocular Microsporidiosis: Case in a Patient Returning from India and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21733266" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : First reported foodborne outbreak associated with microsporidia, Sweden, October 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15567583" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Epidemiology of microsporidiosis: sources and modes of transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10558958" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16820441" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Microsporidian species known to infect humans are present in aquatic birds: implications for transmission via water?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26796229" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Microsporidia - Emergent Pathogens in the Global Food Chain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29029610" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Infection by and genotype characteristics of Enterocytozoon bieneusi in HIV/AIDS patients from Guangxi Zhuang autonomous region, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22403314" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Molecular epidemiologic characterization of Enterocytozoon bieneusi in HIV-infected persons in Benin City, Nigeria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34791090" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Incubation Period, Spore Shedding Duration, and Symptoms of Enterocytozoon bieneusi Genotype C Infection in a Foodborne Outbreak in Denmark, 2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36597327" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Microsporidial Keratitis - First Case Series of a Rare Pathogen in the Wake of Flood Disasters of 2022 in Pakistan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29396924" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Wildlife as an environmental reservoir of Enterocytozoon bieneusi (Microsporidia)–analyses of data based on molecular methods
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29627259" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Molecular and phylogenetic evidences of dispersion of human-infecting microsporidia to vegetable farms via irrigation with treated wastewater: One-year follow up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29457962" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Genotype Identification and Phylogenetic Analysis of Enterocytozoon bieneusi Isolates from Stool Samples of Diarrheic Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8909851" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Enterocytozoon bieneusi infection and diarrheal disease in patients who were not infected with human immunodeficiency virus: case report and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9709895" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Detection of Enterocytozoon bieneusi in two human immunodeficiency virus-negative patients with chronic diarrhea by polymerase chain reaction in duodenal biopsy specimens and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16103591" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Microsporidiosis in travel-associated chronic diarrhea in immune-competent patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24829239" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Extraintestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12792484" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Bilateral microsporidial keratoconjunctivitis in an immunocompetent non-contact lens wearer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12867402" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Microsporidial keratoconjunctivitis in healthy individuals: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28130350" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : In vivo confocal microscopic characteristics of microsporidial keratoconjunctivitis in immunocompetent adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22116156" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Microsporidial keratitis in patients with hot springs exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23598669" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Outbreak of microsporidial keratoconjunctivitis with rugby sport due to soil exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10519226" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Isolation of Nosema algerae from the cornea of an immunocompetent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4202149" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Encephalitozoonosis (nosematosis) of the cornea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1818175" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Corneal microsporidioses: characterization and identification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6423136" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Diagnosis of encephalitozoonosis in man by serological tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28220747" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Three Cases of Neurologic Syndrome Caused by Donor-Derived Microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19364983" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Images in cardiovascular medicine. Endocarditis secondary to microsporidia: giant vegetation in a pacemaker user.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29659738" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Disseminated Infection of Encephalitozoon cuniculi Associated With Osteolysis of Hip Periprosthetic Tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24447398" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Anncaliia algerae microsporidial myositis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25388126" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Microsporidial polymyositis in human immunodeficiency virus-infected patients, a rare life-threatening opportunistic infection: clinical suspicion, diagnosis, and management in resource-limited settings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7578763" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22873400" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : HIV/AIDS-associated opportunistic protozoal diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8416439" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817510" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1456583" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9196210" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Identification of Enterocytozoon bieneusi spores in respiratory samples from an AIDS patient with a 2-year history of intestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9570660" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30063985" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7504651" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Pathology of symptomatic microsporidial (Encephalitozoon hellem) bronchiolitis in the acquired immunodeficiency syndrome: a new respiratory pathogen diagnosed from lung biopsy, bronchoalveolar lavage, sputum, and tissue culture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9455527" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Asymptomatic respiratory tract microsporidiosis due to Encephalitozoon hellem in three patients with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8749639" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Immunologically confirmed disseminated, asymptomatic Encephalitozoon cuniculi infection of the gastrointestinal tract in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8587798" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Development and ultrastructure of Trachipleistophora hominis n.g., n.sp. after in vitro isolation from an AIDS patient and inoculation into athymic mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34460423" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Case Report: First Report of Disseminated Trachipleistophora hominis Infection in an AIDS Patient from Thailand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9868671" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16323101" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9017940" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23947513" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Disseminated microsporidiosis in a renal transplant recipient: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10488225" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24727839" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Microsporidiosis acquired through solid organ transplantation: a public health investigation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28518017" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25132634" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Microsporidiosis in pediatric renal transplant patients in Cape Town, South Africa: two case reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29570921" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: A case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30644064" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Molecular Phylodiagnosis of Enterocytozoon bieneusi and Encephalitozoon intestinalis in Children with Cancer: Microsporidia in Malignancies as an Emerging Opportunistic Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34324771" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34101311" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Microsporidiosis after liver transplantation: A French nationwide retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7540626" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7508457" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12238575" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Diagnostic use of 3 techniques for identification of microsporidian spores among AIDS patients in Portugal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8903228" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Application of molecular techniques to the diagnosis of microsporidial infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8408691" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9554079" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Microsporidiosis: molecular and diagnostic aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10066661" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9143603" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Diagnosis of infections caused by Enterocytozoon bieneusi and Encephalitozoon intestinalis using polymerase chain reaction in stool specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10194459" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8586689" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Comparison of three staining methods for detecting microsporidia in fluids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1370122" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9276399" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Comparative evaluation of modified trichrome and Uvitex 2B stains for detection of low numbers of microsporidial spores in stool specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14769611" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Diagnosis of microsporidia keratitis by polymerase chain reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11693891" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Speciation of human microsporidia by polymerase chain reaction single-strand conformation polymorphism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12490145" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Species-specific detection of three human-pathogenic microsporidial species from the genus Encephalitozoon via fluorogenic 5' nuclease PCR assays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12717629" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15297488" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Evaluation of DNA extraction and PCR methods for detection of Enterocytozoon bienuesi in stool specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12409353" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21183599" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Detection and species identification of microsporidial infections using SYBR Green real-time PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23993212" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Comparison of staining techniques and multiplex nested PCR for diagnosis of intestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15539506" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Monoclonal antibodies for specific detection of Encephalitozoon cuniculi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16148179" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Monoclonal antibodies against Enterocytozoon bieneusi of human origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21323160" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Species identification of intestinal microsporidia using immunofluorescence antibody assays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26307076" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Loop-mediated isothermal amplification for rapid molecular detection of Enterocytozoon bieneusi in faecal specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27206656" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Evaluation of Immunoflourescence antibody assay for the detection of Enterocytozoon bieneusi and Encephalitozoon intestinalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9593027" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10023334" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10795595" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12811545" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Treatment of microsporidiosis including albendazole.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29053792" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11498405" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Drug treatment of microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31145496" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31145496" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15602190" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9365777" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9457096" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11388502" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Therapy for human gastrointestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9598440" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11103042" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7915548" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Clinical features of microsporidiosis in patients with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10930148" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12075057" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Fumagillin treatment of intestinal microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24298986" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33128055" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15954858" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Therapeutic strategies for human microsporidia infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10602740" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36699718" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15841069" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21482878" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Treatment of microsporidia keratitis with topical voriconazole monotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30709889" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Importance of clinical signs leading to the diagnosis in a case of microbiological smear negative ocular microsporidiosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32826651" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Dual Molecular Diagnosis of Microsporidia (Encephalitozoon hellem) Keratoconjunctivitis in an Immunocompetent Adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19815287" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25495852" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Clinical Features, Risk Factors, and Treatments of Microsporidial Epithelial Keratitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35165126" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : A case of stromal microsporidiosis: medical strategies employed for successful resolution.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
